Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Common Equity (2016 - 2026)

Solesence filings provide 17 years of Common Equity readings, the most recent being $17.0 million for Q1 2026.

  • On a quarterly basis, Common Equity rose 11.95% to $17.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $17.0 million, a 11.95% increase, with the full-year FY2025 number at $17.6 million, up 17.98% from a year prior.
  • Common Equity hit $17.0 million in Q1 2026 for Solesence, down from $17.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $18.2 million in Q2 2025 to a low of $1.9 million in Q4 2023.
  • Median Common Equity over the past 5 years was $8.0 million (2022), compared with a mean of $10.4 million.
  • Biggest five-year swings in Common Equity: crashed 66.33% in 2023 and later soared 685.8% in 2024.
  • Solesence's Common Equity stood at $5.6 million in 2022, then plummeted by 66.33% to $1.9 million in 2023, then soared by 685.8% to $14.9 million in 2024, then rose by 17.98% to $17.6 million in 2025, then fell by 3.78% to $17.0 million in 2026.
  • The last three reported values for Common Equity were $17.0 million (Q1 2026), $17.6 million (Q4 2025), and $17.2 million (Q3 2025) per Business Quant data.